Could semaglutide prevent cardiometabolic disease?
Professor Alex Miras, consultant endocrinologist at the University of Ulster, takes the view that obesity is a disease. He explains why this is and how the SELECT trial… read more.
Professor Alex Miras, consultant endocrinologist at the University of Ulster, takes the view that obesity is a disease. He explains why this is and how the SELECT trial… read more.
GLP1 receptor agonists — a class of diabetes medications — are associated with fewer major adverse cardiovascular events than another type of diabetes drug (DPP4 inhibitors) in older… read more.
Semaglutide works well on its own as obesity treatment but it works even better with the support and guidance of a multi-disciplinary weight-management team, according to Alex Miras,… read more.
In March 2023 the National Institute for Health and Care Excellence (NICE) published Technology Appraisal Guidance for semaglutide for obesity. Professor Alex Miras explains the guidance and its… read more.
Alex Miras is Professor of Endocrinology at the University of Ulster, UK and is an expert in obesity management and research. In 2021 a trial of semaglutide for… read more.
Exenatide, an injectable treatment for type 2 diabetes, has shown efficacy for the treatment of ‘blinding’ headaches known as idiopathic intercranial hypertension (IIH). Researchers from a phase 2… read more.
Patients with ‘blinding’ headaches known as Idiopathic Intercranial Hypertension (IIH) could be treated with an injectable peptide used for type 2 diabetes, a new trial has found. The… read more.
Snapshot survey data from the 7th National Audit Project of the Royal College of Anaesthetists (NAP7) published in Anaesthesia (a journal of the Association of Anaesthetists) reveals an extremely worrying picture… read more.
A new study, published in the European Journal of Public Health based on data from 25,049 children aged three to five, shows an increase in obesity during the COVID-19… read more.
The implementation of the two-tier soft drinks industry levy in the UK in 2018 was associated with an 8% reduction in obesity among 10-11 year old girls, with… read more.
For many people, keeping a healthy body weight can be a challenge. According to the Centers for Disease Control and Prevention, among adults 20 years-old and over, the prevalence… read more.
A new research study published today in Family Practice, published by Oxford University Press, finds that when doctors tell patients living with obesity to lose weight the guidance they give is… read more.
Advertisment